FARMAK AS

Overview

FARMAK AS is an active pharmaceutical ingredient (API) supplier with 7 active FDA Type II Drug Master Files, covering BRIMONIDINE TARTRATE; BROENAC SODIUM; DOFETILIDE; REGADENOSON; TIZANIDINE HCL; WARFARIN SODIUM.

Core services & business areas

Active pharmaceutical ingredients supplied

Substances FARMAK AS is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.

API / Drug Master Files

FARMAK AS holds 3 active (14 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• BROMFENAC SODIUMActive2023-10-18
• DOFETILIDEActive2017-07-24
• TIZANIDINE HCLActive2001-07-04
• TAFAMIDIS MEGLUMINE (NON-MICRONIZED)Inactive2023-09-26
• ZILEUTON USPInactive2017-09-19
• SELEGILINE HYDROCHLORIDE USPInactive2016-10-06
• ZILEUTONInactive2013-10-30
• REGADENOSON MONOHYDRATEInactive2012-04-02
• ZOPICLONEInactive2008-12-24
• ESZOPICLONEInactive2008-03-07
• QUETIAPINE FUMARATEInactive2007-09-17
• ALFUZOSIN HYDROCHLORIDEInactive2006-05-26
• DILTIAZEM HYDROCHLORIDEInactive2001-05-04
• KETOROLAC TROMETHAMINEInactive1997-06-17

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to FARMAK AS in our records. PharmaTek screens the full directory against live FDA enforcement data.